Serebryany; Vladimir
Patent Applications and Registrations
Patent applications and USPTO patent grants for Serebryany; Vladimir.The latest application filed is for "pyrrole compounds".
Company Profile
2.15.29
- Serebryany; Vladimir - Burlingame CA
- Serebryany; Vladimir - Burlingme CA
Patent Activity
| Patent | Date |
|---|---|
| Pyrrole Compounds App 20220071957 - Vendeville; Sandrine ; et al. | 2022-03-10 |
| Anti-viral Compounds App 20220009903 - Vandyck; Koen ; et al. | 2022-01-13 |
| Pyrrole compounds Grant 11,191,747 - Vendeville , et al. December 7, 2 | 2021-12-07 |
| Pyrrole Compounds App 20200323821 - Vendeville; Sandrine ; et al. | 2020-10-15 |
| Methods of preparing substituted nucleoside analogs Grant 10,519,185 - Serebryany , et al. Dec | 2019-12-31 |
| Compounds and methods for treating inflammatory and fibrotic disorders Grant RE47,142 - Kossen , et al. Nov | 2018-11-27 |
| Methods Of Preparing Substituted Nucleoside Analogs App 20180186825 - Serebryany; Vladimir ; et al. | 2018-07-05 |
| Method of modulating stress-activated protein kinase system Grant 10,010,536 - Blatt , et al. July 3, 2 | 2018-07-03 |
| Methods of preparing substituted nucleoside analogs Grant 9,908,914 - Serebryany , et al. March 6, 2 | 2018-03-06 |
| Method Of Modulating Stress-activated Protein Kinase System App 20170095462 - Blatt; Lawrence M. ; et al. | 2017-04-06 |
| Method of modulating stress-activated protein kinase system Grant 9,527,816 - Blatt , et al. December 27, 2 | 2016-12-27 |
| Methods Of Preparing Substituted Nucleoside Analogs App 20160115190 - Serebryany; Vladimir ; et al. | 2016-04-28 |
| Compounds and methods for treating inflammatory and fibrotic disorders Grant 9,290,450 - Kossen , et al. March 22, 2 | 2016-03-22 |
| Methods Of Preparing Substituted Nucleotide Analogs App 20150368286 - Serebryany; Vladimir ; et al. | 2015-12-24 |
| Compounds and methods for treating inflammatory and fibrotic disorders Grant 8,969,347 - Kossen , et al. March 3, 2 | 2015-03-03 |
| Methods of preparing substituted nucleotide analogs Grant 8,895,723 - Serebryany , et al. November 25, 2 | 2014-11-25 |
| Methods of preparing substituted nucleotide analogs Grant 8,846,896 - Serebryany , et al. September 30, 2 | 2014-09-30 |
| Compounds And Methods For Treating Inflammatory And Fibrotic Disorders App 20140235637 - Kossen; Karl ; et al. | 2014-08-21 |
| Method Of Modulating Stress-activated Protein Kinase System App 20140228310 - Blatt; Lawrence M. ; et al. | 2014-08-14 |
| Method of modulating stress-activated protein kinase system Grant 8,741,936 - Blatt , et al. June 3, 2 | 2014-06-03 |
| Methods Of Preparing Substituted Nucleotide Analogs App 20130281687 - Serebryany; Vladimir ; et al. | 2013-10-24 |
| Methods Of Preparing Substituted Nucleotide Analogs App 20130253181 - Serebryany; Vladimir ; et al. | 2013-09-26 |
| Compounds And Methods For Treating Inflammatory And Fibrotic Disorders App 20130102597 - Kossen; Karl ; et al. | 2013-04-25 |
| Compounds and methods for treating inflammatory and fibrotic disorders Grant 8,304,413 - Kossen , et al. November 6, 2 | 2012-11-06 |
| Method Of Modulating Stress-activated Protein Kinase System App 20120258924 - Blatt; Lawrence M. ; et al. | 2012-10-11 |
| Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication App 20120251493 - Seiwert; Scott D. ; et al. | 2012-10-04 |
| Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication App 20120101032 - BUCKMAN; Brad ; et al. | 2012-04-26 |
| Substituted Proline Inhibitors Of Hepatitis C Virus Replication App 20120095211 - Buckman; Brad ; et al. | 2012-04-19 |
| Novel Inhibitors Of Hepatitis C Virus Replication App 20120094897 - Buckman; Brad ; et al. | 2012-04-19 |
| Novel Inhibitors Of Hepatitis C Virus Replication App 20110312996 - Buckman; Brad ; et al. | 2011-12-22 |
| Macrocyclic inhibitors of hepatitis C virus replication Grant 8,048,862 - Seiwert , et al. November 1, 2 | 2011-11-01 |
| Novel Inhibitors Of Hepatitis C Virus Replication App 20110152246 - Buckman; Brad ; et al. | 2011-06-23 |
| Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication App 20110129444 - BUCKMAN; BRAD ; et al. | 2011-06-02 |
| Therapeutic Antiviral Peptides App 20110082182 - Buckman; Brad ; et al. | 2011-04-07 |
| Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication App 20110081315 - Buckman; Brad ; et al. | 2011-04-07 |
| Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication App 20110059047 - Seiwert; Scott D. ; et al. | 2011-03-10 |
| Method of Modulating Stress-Activated Protein Kinase System App 20110034495 - Seiwert; Scott D. ; et al. | 2011-02-10 |
| Method Of Modulating Stress-activated Protein Kinase System App 20100240704 - Blatt; Lawrence M. ; et al. | 2010-09-23 |
| Method of modulating stress-activated protein kinase system Grant 7,728,013 - Blatt , et al. June 1, 2 | 2010-06-01 |
| Therapeutic Antiviral Peptides App 20100119479 - BUCKMAN; BRAD ; et al. | 2010-05-13 |
| Compounds And Methods For Treating Inflammatory And Fibrotic Disorders App 20090318455 - Kossen; Karl ; et al. | 2009-12-24 |
| Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication App 20090269305 - Seiwert; Scott D. ; et al. | 2009-10-29 |
| Novel Inhibitors Of Hepatitis C Virus Replication App 20090047246 - Beigelman; Leonid ; et al. | 2009-02-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 